Spanish private equity firm Abac Capital and the management team of dietary business PronoKal have acquired the company from its founders.
PronoKal provides protein-based dietary treatments for obesity and overweight, with sales in excess of €42m and presence in 15 countries in Europe and Latin America.
The Barcelona-based company’s offering includes nutritional products, medical supervision, personalised dietary advice, personal training and coaching services.
In Spain, which accounts for 49 per cent of sales, PronoKal has a patient base of over 300,000 people and more than 2,500 prescribing doctors.
PronoKal Group is also present in the United Kingdom, Belgium, the Netherlands, Mexico, Argentina, Peru and Brazil, among other markets.
The company is planning nine new openings over the next five years in countries such as Colombia, Chile or Italy, with the aim of doubling its revenue base.
PronoKal Group is Abac’s third investment, following the acquisition of Grupo Metalcaucho and Figueras International Seating.